DRLAX | MGLMX | DRLAX / MGLMX | |
Total Expense Ratio | 1.30 | 0.94 | 138% |
Annual Report Gross Expense Ratio | 1.77 | 0.95 | 186% |
Fund Existence | 19 years | 11 years | - |
Gain YTD | 6.683 | 3.611 | 185% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 304M | 2.22B | 14% |
Annual Yield % from dividends | 2.31 | 2.51 | 92% |
Returns for 1 year | 9.95 | 2.42 | 412% |
Returns for 3 years | 4.34 | -3.45 | -126% |
Returns for 5 years | 24.66 | 15.05 | 164% |
Returns for 10 years | 15.64 | 23.15 | 68% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MSAZX | 29.98 | 0.13 | +0.44% |
Invesco Main Street All Cap R5 | |||
TRZKX | 75.82 | 0.17 | +0.22% |
T. Rowe Price International Discovery Z | |||
DBICX | 10.34 | 0.01 | +0.10% |
DWS Global Macro C | |||
MMKBX | 24.05 | -0.09 | -0.37% |
Morgan Stanley Inst Emerging Mkts A | |||
EMQIX | 9.25 | -0.04 | -0.43% |
Ashmore Emerging Markets Active Eq Instl |